Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Solid Tumor Cancer × Paclitaxel × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 11 Breast Neoplasms 9 Triple Negative Breast Neoplasms 8 Endometrial Neoplasms 8 Ovarian Neoplasms 6 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Stomach Neoplasms 3 Recurrence 3 Neoplasms 3 Esophageal Neoplasms 3 Small Cell Lung Carcinoma 2 Pancreatic Neoplasms 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Fallopian Tube Neoplasms 2 Urinary Bladder Neoplasms 1 Unresectable Locally Advanced or Metastatic Solid Tumors 1 Thyroid Neoplasms 1 Stage III and IV Ovarian Cancer 1 Squamous Non-small Cell Lung Cancer 1 Solid Tumor Cancer 1 Sarcoma, Kaposi 1 Respiratory Tract Neoplasms 1 Platinum-Resistant Primary Peritoneal Carcinoma 1 Pathologic Complete Response 1 PDAC - Pancreatic Ductal Adenocarcinoma 1 Oropharyngeal Neoplasms 1 NSCLC 1 Multiple Myeloma 1

Interventions

irinotecan sucrosofate 1 Vincristine 1 Temozolomide 1 TP protocol 1 Pemetrexed 1 Paclitaxel 1 PE regimen 1 Immunotherapy 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06649448 2024-10-18

EF-001

Shandong Cancer Hospital and Institute

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡